| EGFR-AS1 |
|
EGFR antisense RNA 1
|
|
|
0.722 |
0.192 |
| PPP6C |
O00743
|
protein phosphatase 6 catalytic subunit
|
|
0.86 |
0.729 |
0.231 |
| EPHA2 |
P29317
|
EPH receptor A2
|
Kinase
|
1.1E-05 |
0.501 |
0.731 |
| MED12 |
Q93074
|
mediator complex subunit 12
|
Transcription factor
|
1.00 |
0.476 |
0.769 |
| DDR2 |
Q16832
|
discoidin domain receptor tyrosine kinase 2
|
Kinase
|
0.55 |
0.541 |
0.769 |
| FGFR2 |
P21802
|
fibroblast growth factor receptor 2
|
Kinase
|
1.00 |
0.380 |
0.808 |
| CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
| STK11 |
Q15831
|
serine/threonine kinase 11
|
Kinase
|
0.99 |
0.435 |
0.808 |
| FBXW7 |
Q969H0
|
F-box and WD repeat domain containing 7
|
Enzyme modulator
|
1.00 |
0.465 |
0.808 |
| BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
| FGFR3 |
P22607
|
fibroblast growth factor receptor 3
|
Kinase
|
1.6E-05 |
0.391 |
0.846 |
| EP300 |
Q09472
|
E1A binding protein p300
|
|
1.00 |
0.459 |
0.846 |
| B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| NFE2L2 |
Q16236
|
nuclear factor, erythroid 2 like 2
|
Enzyme
|
3.6E-03 |
0.357 |
0.885 |
| PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
| PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
| PIK3CA |
P42336
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
Kinase
|
1.00 |
0.292 |
0.923 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |